Le Lézard
Classified in: Health
Subjects: BFA, ACC

Candid and National Dental expand access to affordable clear aligner therapy in NYC


NEW YORK, April 19, 2022 /PRNewswire/ -- Running a successful DSO in the New York City market takes innovation, empathy, and a growth mindset. That's why National Dental has recently tapped Candid as a new clear aligner partner. With Candid's convenient and affordable clear aligner system, National Dental aims to boost case starts and expand their orthodontic capabilities while helping their team streamline their workflows. 

"Our team is excited to offer Candid clear aligners because the treatment process is so convenient" says Dr. Doshi.

National Dental's offices are known for providing comprehensive dental care?including the latest in orthodontic treatments?to the patients they serve. Since 2016, National Dental has garnered a reputation for clinical excellence among patients and a deep dedication to their team. Under Dr. Nitin Doshi's guidance, National Dental has expanded throughout the New York Metro area.

For Candid, aligning with DSOs like National Dental is key to expanding their footprint in major markets. 

"We're seeing a lot of interest from DSOs that want a more efficient way to provide orthodontic treatment to their patients," says Candid's Senior Vice President of Sales, Brian Ganey. "We're looking forward to helping National Dental leverage our clear aligner system to drive business growth while transforming their patients' smiles."

For Dr. Doshi, partnering with Candid will help National Dental stand out from the competition and help its practices scale their orthodontic capabilities with minimal impacts to in-office scheduling. 

"Our team is excited to offer Candid clear aligners because the treatment process is so convenient for our practices and patients alike," says Dr. Doshi. "By minimizing in-person appointments and engaging patients in their treatment with CandidApptm, our practices will be better equipped to meet the growing demand for clear aligners without eating up the chair time required to carry out other therapies our patients need." 

Candid's clear aligner system reduces the need for routine in-person aligner checks by tracking every patient's progress virtually with CandidMonitoringtm. Using this system, patients share photos of their teeth with their dentist every 14 days to ensure treatment is on schedule.

"We think Candid will help our practices cement themselves as clear aligner leaders in our market," says Dr. Doshi. "With Candid's streamlined clear aligner workflow, we estimate that our monthly case starts will increase by at least 50% while maintaining current staffing levels and keeping chair time free for other revenue-generating procedures."

About Candid 
Candid is a clear aligner orthodontic system that makes treatment accessible and affordable for doctors and patients. Since 2020, Candid has brought high-quality clear aligners and patient support to dental practices and dental service organizations across the United States via CandidPro. Learn more at candidco.com.

About National Dental 
Founded in 2016, National Dental is a New York-based DSO known for its high standard of care across all locations. Under the leadership of Dr. Nitin Doshi, National Dental strives to bring the latest in dental technology to its patients and is committed to growth, innovation, and education. Learn more at lovenationaldental.com.

SOURCE Candid


These press releases may also interest you

at 05:09
Medical imaging IT and cybersecurity company Sectra (STO: SECT B) is publishing its Annual Report and Sustainability Report for the 2023/2024 fiscal year today. This report also includes the Corporate Governance Report for the same period. The...

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...



News published on and distributed by: